Patient characteristics
| Characteristic . | No. of patients (n = 40) . |
|---|---|
| Sex | |
| Male | 30 |
| Female | 10 |
| Age, y | |
| Median | 55 |
| Range | 34-68 |
| Prior treatment | |
| No. of lines of CTX | |
| Median | 4 |
| Range | 2-8 |
| Prior autologous HCT | 22 |
| Donor | |
| Related | 13 |
| Unrelated | 27 |
| Diagnosis/histology | |
| Follicular NHL grade 1 or 2 | 17 |
| CLL | 13 |
| MCL | 8 |
| MZL | 1 |
| Lymphoplasmacytic lymphoma | 1 |
| LDH at inclusion | |
| Less than 250 U/mL | 25 |
| 250 U/mL or more | 15 |
| EBMT-HCT score15 | |
| 4 | 2 |
| 5 | 8 |
| 6 | 27 |
| 7 | 3 |
| Disease status at HCT | |
| CR | 7 |
| PR | 27 |
| SD | 6 |
| Less than 5 cm largest LN | 33 |
| 5 cm or more largest LN | 7 |
| Characteristic . | No. of patients (n = 40) . |
|---|---|
| Sex | |
| Male | 30 |
| Female | 10 |
| Age, y | |
| Median | 55 |
| Range | 34-68 |
| Prior treatment | |
| No. of lines of CTX | |
| Median | 4 |
| Range | 2-8 |
| Prior autologous HCT | 22 |
| Donor | |
| Related | 13 |
| Unrelated | 27 |
| Diagnosis/histology | |
| Follicular NHL grade 1 or 2 | 17 |
| CLL | 13 |
| MCL | 8 |
| MZL | 1 |
| Lymphoplasmacytic lymphoma | 1 |
| LDH at inclusion | |
| Less than 250 U/mL | 25 |
| 250 U/mL or more | 15 |
| EBMT-HCT score15 | |
| 4 | 2 |
| 5 | 8 |
| 6 | 27 |
| 7 | 3 |
| Disease status at HCT | |
| CR | 7 |
| PR | 27 |
| SD | 6 |
| Less than 5 cm largest LN | 33 |
| 5 cm or more largest LN | 7 |
CTX indicates chemotherapy; LDH, lactate dehydrogenase; and LN, lymph node.